106 related articles for article (PubMed ID: 10501428)
1. Effectiveness and risks of total body irradiation for conditioning in the treatment of autoimmune disease with autologous bone marrow transplantation.
van Bekkum DW
Rheumatology (Oxford); 1999 Aug; 38(8):757-61. PubMed ID: 10501428
[TBL] [Abstract][Full Text] [Related]
2. Rationale for high-dose cyclophosphamide and medium-dose total body irradiation in the conditioning of children with progressive systemic and polyarticular juvenile chronic arthritis before autologous stem cell transplantation.
Vossen JM; Brinkman DM; Bakker B; Hoogerbrugge PM; ten Cate R
Rheumatology (Oxford); 1999 Aug; 38(8):762-3. PubMed ID: 10501429
[No Abstract] [Full Text] [Related]
3. Autologous stem cell transplantation: a possible treatment for refractory juvenile chronic arthritis?
Wulffraat NM; Kuis W
Rheumatology (Oxford); 1999 Aug; 38(8):764-6. PubMed ID: 10501430
[TBL] [Abstract][Full Text] [Related]
4. Stem cell transplantation for severe autoimmune diseases: progress and problems.
Marmont AM
Haematologica; 1998 Aug; 83(8):733-43. PubMed ID: 9793258
[TBL] [Abstract][Full Text] [Related]
5. Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis.
Wulffraat N; van Royen A; Bierings M; Vossen J; Kuis W
Lancet; 1999 Feb; 353(9152):550-3. PubMed ID: 10028984
[TBL] [Abstract][Full Text] [Related]
6. Conditioning regimens for the treatment of experimental arthritis with autologous bone marrow transplantation.
van Bekkum DW
Bone Marrow Transplant; 2000 Feb; 25(4):357-64. PubMed ID: 10723577
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K
Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
[TBL] [Abstract][Full Text] [Related]
8. Total body irradiation compared with BEAM: Long-term outcomes of peripheral blood autologous stem cell transplantation for non-Hodgkin's lymphoma.
Liu HW; Seftel MD; Rubinger M; Szwajcer D; Demers A; Nugent Z; Schroeder G; Butler JB; Cooke A
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):513-20. PubMed ID: 20137862
[TBL] [Abstract][Full Text] [Related]
9. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.
Jillella AP; Doria R; Khan K; Zelterman D; Ahmad YH; Smith BR; Holmes W; Becker P; Roberts KB; Rappeport JM
Bone Marrow Transplant; 1999 Jun; 23(11):1095-100. PubMed ID: 10382947
[TBL] [Abstract][Full Text] [Related]
10. Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukemia.
Chemnitz JM; von Lilienfeld-Toal M; Holtick U; Theurich S; Shimabukuro-Vornhagen A; Krause A; Brossart P; Hallek M; Scheid C
Ann Hematol; 2012 Jan; 91(1):47-55. PubMed ID: 21584670
[TBL] [Abstract][Full Text] [Related]
11. Dose response and factors related to interstitial pneumonitis after bone marrow transplant.
Sampath S; Schultheiss TE; Wong J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):876-84. PubMed ID: 16199317
[TBL] [Abstract][Full Text] [Related]
12. Effective treatment of relapsing experimental autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation.
van Gelder M; van Bekkum DW
Bone Marrow Transplant; 1996 Dec; 18(6):1029-34. PubMed ID: 8971369
[TBL] [Abstract][Full Text] [Related]
13. Total body irradiation in allogeneic bone marrow transplantation conditioning regimens: A review.
Paix A; Antoni D; Waissi W; Ledoux MP; Bilger K; Fornecker L; Noel G
Crit Rev Oncol Hematol; 2018 Mar; 123():138-148. PubMed ID: 29482775
[TBL] [Abstract][Full Text] [Related]
14. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease.
Miralbell R; Bieri S; Mermillod B; Helg C; Sancho G; Pastoors B; Keller A; Kurtz JM; Chapuis B
J Clin Oncol; 1996 Feb; 14(2):579-85. PubMed ID: 8636774
[TBL] [Abstract][Full Text] [Related]
15. Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Ravinet A; Cabrespine A; Socié G; Milpied N; Yakoub Agha I; Nguyen S; Michallet M; Menard AL; Maillard N; Mohty M; Suarez F; Huynh A; Marchand T; Deteix C; Cassuto JP; Maury S; Chevallier P; Reman O; Peffault de Latour R; Bay JO
Transplantation; 2016 Aug; 100(8):1732-9. PubMed ID: 26528768
[TBL] [Abstract][Full Text] [Related]
16. A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.
Soderling CC; Song CW; Blazar BR; Vallera DA
J Immunol; 1985 Aug; 135(2):941-6. PubMed ID: 3891856
[TBL] [Abstract][Full Text] [Related]
17. Factors Influencing Pulmonary Toxicity in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in the Setting of Total Body Irradiation-Based Myeloablative Conditioning.
Abugideiri M; Nanda RH; Butker C; Zhang C; Kim S; Chiang KY; Butker E; Khan MK; Haight AE; Chen Z; Esiashvili N
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):349-59. PubMed ID: 26853343
[TBL] [Abstract][Full Text] [Related]
18. Acute renal toxicity of 2 conditioning regimens in patients undergoing autologous peripheral blood stem-cell transplantation. Total body irradiation-cyclophosphamide versus ifosfamide, carboplatin, etoposide.
Beyzadeoglu M; Arpaci F; Surenkok S; Ozyigit G; Oysul K; Caglar K; Ataergin S; Yenicesu M; Kaya A
Saudi Med J; 2008 Jun; 29(6):832-6. PubMed ID: 18521460
[TBL] [Abstract][Full Text] [Related]
19. Effect of conditioning regimen on the outcome of bone marrow transplantation from an unrelated donor.
Kanda Y; Sakamaki H; Sao H; Okamoto S; Kodera Y; Tanosaki R; Kasai M; Hiraoka A; Takahashi S; Miyawaki S; Kawase T; Morishima Y; Kato S;
Biol Blood Marrow Transplant; 2005 Nov; 11(11):881-9. PubMed ID: 16275591
[TBL] [Abstract][Full Text] [Related]
20. Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation.
Karussis DM; Vourka-Karussis U; Lehmann D; Ovadia H; Mizrachi-Koll R; Ben-Nun A; Abramsky O; Slavin S
J Clin Invest; 1993 Aug; 92(2):765-72. PubMed ID: 7688762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
